Research programme: Graves' disease therapeutics - Thyritope Biosciences

Drug Profile

Research programme: Graves' disease therapeutics - Thyritope Biosciences

Alternative Names: Thyroid hormone modulators - Thyritope Biosciences; Thyroid-stimulating antibody inhibitors - Thyritope Biosciences

Latest Information Update: 26 Sep 2014

Price : $50

At a glance

  • Originator Thyritope Biosciences
  • Class
  • Mechanism of Action Thyroid-stimulating immunoglobulin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Graves' disease

Most Recent Events

  • 22 Sep 2014 Early research in Graves' disease in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top